Simons Chase discusses biotech opportunities in the emerging trend to fight obesity with the new class of GLP-1 agonist Here Are 3 Clinical Stage GLP-1







The Obesity Epidemic and Biotech Innovation: Unveiling Opportunities in GLP-1 Agonists [diet pill death]

The Obesity Epidemic and Biotech Innovation: Unveiling Opportunities in GLP-1 Agonists [diet pill death]

| 1h 28m 28s | Video has closed captioning.

Simons Chase discusses biotech opportunities in the emerging trend to fight obesity with the new class of GLP-1 agonist Here Are 3 Clinical Stage GLP-1 Agonist Biotechs An Interview With NeuroBo CEO Dual Agonists Push Weight Loss Drug Companies Into Full Bandwagon Mode

Aired: May 28, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of The Obesity Epidemic and Biotech Innovation: Unveiling Opportunities in GLP-1 Agonists [diet pill death] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into The Obesity Epidemic and Biotech Innovation: Unveiling Opportunities in GLP-1 Agonists [diet pill death] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how The Obesity Epidemic and Biotech Innovation: Unveiling Opportunities in GLP-1 Agonists [diet pill death] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now